Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans

We are issuing this notice to help drug manufacturers and sponsors when preparing the Canadian-specific considerations and elements in the risk management plans (RMPs) for certain drug products. This notice describes what is required for certain drug products.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2024-04-04

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data